Zhijian Xu
zjxu@simm.ac.cn
Chinese, English
Shanghai
University of Chinese Academy of Sciences
Medical School
  • 2007-09--2012-06 Ph.D. in Science: Shanghai Institute of Materia Medica, Chinese Academy of Sciences
  • 2003-09--2007-07 Bachelor's in Science: Shandong University
  • Published 156 papers, including 149 SCI papers
  • Applied for 51 national invention patents and 6 software copyrights
  • 2021-10~Present - Shanghai Institute of Materia Medica, Chinese Academy of Sciences - Researcher
  • 2015-10~2021-09 - Shanghai Institute of Materia Medica, Chinese Academy of Sciences - Associate Researcher
  • 2014-08~2015-09 - Shanghai Institute of Materia Medica, Chinese Academy of Sciences - Assistant Researcher
  • 2012-07~2014-07 - Shanghai Institute of Materia Medica, Chinese Academy of Sciences - Postdoctoral Researcher
  • National Excellent Young Scientist Fund (Medical Department)
  • Mingzhu Elite Talent
Molecular Simulation and Drug Design
Development of New Methods for Molecular Simulation and Drug Design
Application of These Methods in Drug Discovery
  • D3CARP: a comprehensive platform with multiple-conformation based docking, ligand similarity search and deep learning approaches for target prediction and virtual screening, Yulong Shi, Xinben Zhang, Yanqing Yang, Tingting Cai, Cheng Peng, Leyun Wu, Liping Zhou, Jiaxin Han, Minfei Ma, Weiliang Zhu, Zhijian Xu, 2023
  • Preferred microenvironments of halogen bonds and hydrogen bonds revealed using statistics and QM/MM calculation studies, Liping Zhou, Jintian Li, Yulong Shi, Leyun Wu, Weiliang Zhu, Zhijian Xu, 2023
  • Molecular dynamics study on the behavior and binding mechanism of target protein Transgelin-2 with its agonist TSG12 for anti-asthma drug discovery, Leyun Wu, Guangpu Wang, Liping Zhou, Mengxia Mo, Yulong Shi, Bo Li, Leimiao Yin, Qiang Zhao, Yongqing Yang, Chengkun Wu, Zhijian Xu, Weiliang Zhu, 2023
  • Preventive and therapeutic benefits of nelfinavir in rhesus macaques and human beings infected with SARS-CoV-2, Zhijian Xu, Danrong Shi, Jian-Bao Han, Yun Ling, Xiangrui Jiang, Xiangyun Lu, Chuan Li, Likun Gong, Guangbo Ge, Yani Zhang, Yi Zang, Tian-Zhang Song, Xiao-Li Feng, Ren-Rong Tian, Jia Ji, Miaojin Zhu, Nanping Wu, Chunhui Wu, Zhen Wang, Yechun Xu, Cheng Peng, Min Zheng, Junling Yang, Feifei Du, Junliang Wu, Peipei Wang, Jingshan Shen, Jianliang Zhang, Yong-Tang Zheng, Hangping Yao, Weiliang Zhu, 2023
  • Development of a Novel 18F-Labeled Probe for PET Imaging of Estrogen Receptor β, Yujing Zhou, Peng Lei, Jiaxin Han, Zhiming Wang, Aiyan Ji, Yuyang Wu, Lingling Zheng, Xiaoqing Zhang, Chunrong Qu, Jian Min, Weiliang Zhu, Zhijian Xu, Xingdang Liu, Hao Chen, Zhen Cheng, 2023
  • Molecular dynamics study on the behavior and binding mechanism of target protein Transgelin-2 with its agonist TSG12 for anti-asthma drug discovery, Leyun Wu, Guangpu Wang, Liping Zhou, Mengxia Mo, Yulong Shi, Bo Li, Leimiao Yin, Qiang Zhao, Yongqing Yang, Chengkun Wu, Zhijian Xu, Weiliang Zhu, 2023
  • Halogen bonds exist between noncovalent ligands and natural nucleic acids, Kaijie Mu, Zhengdan Zhu, Amina Abula, Cheng Peng, Weiliang Zhu, Zhijian Xu, 2022
  • SARS-CoV-2 Omicron RBD shows weaker binding affinity than the currently dominant Delta variant to human ACE2, Leyun Wu, Liping Zhou, Mengxia Mo, Tingting Liu, Chengkun Wu, Chunye Gong, Kai Lu, Likun Gong, Weiliang Zhu, Zhijian Xu, 2022
  • Exploring the Binding Affinity and Mechanism between ACE2 and the Trimers of Delta and Omicron Spike Proteins by Molecular Dynamics Simulation and Bioassay, Liping Zhou, Tingting Liu, Mengxia Mo, Yulong Shi, Leyun Wu, Yishui Li, Qiuping Qin, Weiliang Zhu, Chengkun Wu, Likun Gong, Zhijian Xu, 2022
  • Preclinical validation and phase I trial of 4-hydroxysalicylanilide, targeting ribonucleotide reductase mediated dNTP synthesis in multiple myeloma, Yongsheng Xie, Yingcong Wang, Zhijian Xu, Yumeng Lu, Dongliang Song, Lu Gao, Dandan Yu, Bo Li, Gege Chen, Hui Zhang, Qilin Feng, Yong Zhang, Ke Hu, Cheng Huang, Yu Peng, Xiaosong Wu, Zhiyong Mao, Jimin Shao, Weiliang Zhu, Jumei Shi, 2022
  • D3AI-Spike: A deep learning platform for predicting binding affinity between SARS-CoV-2 spike Receptor Binding Domain with multiple amino acid mutations and human angiotensin-converting enzyme 2, Jiaxin Han, Tingting Liu, Xinben Zhang, Yanqing Yang, Yulong Shi, Jintian Li, Minfei Ma, Weiliang Zhu, Likun Gong, Zhijian Xu, 2022
  • Exploring the immune evasion of SARS-CoV-2 variant harboring E484K by molecular dynamics simulations, Leyun Wu, Cheng Peng, Yanqing Yang, Yulong Shi, Liping Zhou, Zhijian Xu, Weiliang Zhu, 2022
  • MultiDTI: Drug-target interaction prediction based on multi-modal representation learning to bridge the gap between new chemical entities and known heterogeneous network, Deshan Zhou, Zhijian Xu, Wentao Li, Xiaolan Xie, Shaoliang Peng, 2021
  • Ligand-based approach for predicting drug targets and for virtual screening against COVID-19, Yanqing Yang, Zhengdan Zhu, Xiaoyu Wang, Xinben Zhang, Kaijie Mu, Yulong Shi, Cheng Peng, Zhijian Xu, Weiliang Zhu, 2021
  • Identification and mechanistic analysis of an inhibitor of the CorC Mg2+ transporter, Yichen Huang, Kaijie Mu, Xinyu Teng, Yimeng Zhao, Yosuke Funato, Hiroaki Miki, Weiliang Zhu, Zhijian Xu, Motoyuki Hattori, 2021
  • Computational Insights into the Conformational Accessibility and Binding Strength of SARS-CoV-2 Spike Protein to Human Angiotensin-Converting Enzyme 2, Cheng Peng, Zhengdan Zhu, Yulong Shi, Xiaoyu Wang, Kaijie Mu, Yanqing Yang, Xinben Zhang, Zhijian Xu, Weiliang Zhu, 2020
  • Substitution Effect of the Trifluoromethyl Group on the Bioactivity in Medicinal Chemistry: Statistical Analysis and Energy Calculations, Amina Abula, Zhijian Xu, Zhengdan Zhu, Cheng Peng, Zhaoqiang Chen, Weiliang Zhu, Haji Akber Aisa, 2020
  • D3Targets-2019-nCoV: a webserver for predicting drug targets and for multi-target and multi-site based virtual screening against COVID-19, Yulong Shi, Xinben Zhang, Kaijie Mu, Cheng Peng, Zhengdan Zhu, Xiaoyu Wang, Yanqing Yang, Zhijian Xu, Weiliang Zhu, 2020
  • 抗致病性冠状病毒活性化合物及其潜在靶标蛋白研究进展, 王晓宇,彭诚,杨延青,石禹龙,朱正诞,穆凯洁,李慧玉,徐志建,朱维良, 2020
  • Interaction Nature and Computational Methods for Halogen Bonding: A Perspective, Zhengdan Zhu, Zhijian Xu, Weiliang Zhu, 2020
  • Underestimated noncovalent interactions in Protein Data Bank, Zhijian Xu, Qian Zhang, Jiye Shi, Weiliang Zhu, 2019
  • Halogen bonding in differently charged complexes: basic profile, essential interaction terms and intrinsic sigma-hole, Zhengdan Zhu, Guimin Wang, Zhijian Xu, Zhaoqiang Chen, Jinan Wang, Jiye Shi, Weiliang Zhu, 2019
  • D3Pockets: A Method and Web Server for Systematic Analysis of Protein Pocket Dynamics, Zhaoqiang Chen, Xinben Zhang, Cheng Peng, Jinan Wang, Zhijian Xu, Kaixian Chen, Jiye Shi, Weiliang Zhu, 2019
  • Rafoxanide, an organohalogen drug, triggers apoptosis and cell cycle arrest in multiple myeloma by enhancing DNA damage responses and suppressing the p38 MAPK pathway, Wenqin Xiao, Zhijian Xu, Shuaikang Chang, Bo Li, Dandan Yu, Huiqun Wu, Yongsheng Xie, Yingcong Wang, Bingqian Xie, Xi Sun, Yuanyuan Kong, Xiucai Lan, Wenxuan Bu, Gege Chen, Lu Gao, Xiaosong Wu, Jumei Shi, Weiliang Zhu, 2019
  • Underestimated Halogen Bonds Forming with Protein Backbone in Protein Data Bank, Qian Zhang, Zhijian Xu, Shi Jiye, Weiliang Zhu, 2017
  • The Underestimated Halogen Bonds Forming with Protein Side Chains in Drug Discovery and Design, Qian Zhang, Zhijian Xu, Weiliang Zhu, 2017
  • How do Distance and Solvent Affect the Halogen Bonding Involving Negatively Charged Donors?, Zhaoqiang Chen, Guimin Wang, Zhijian Xu, Jinan Wang, Yuqi Yu, Tingting Cai, Qiang Shao, Jiye Shi, Weiliang Zhu, 2016
  • Repositioning organohalogen drugs: a case study for identification of potent B-Raf V600E inhibitors via docking and bioassay, Yisu Li, Binbin Guo, Zhijian Xu, Bo Li, Tingting Cai, Xinben Zhang, Yuqi Yu, Heyao Wang, Jiye Shi, Weiliang Zhu, 2016
  • Stability and Characteristics of the Halogen Bonding Interaction in an Anion-Anion Complex: A Computational Chemistry Study, Guimin Wang, Zhaoqiang Chen, Zhijian Xu, Jinan Wang, Yang Yang, Tingting Cai, Jiye Shi, Weiliang Zhu, 2016
Molecular Simulation Drug Design Halogen Bond Hydrogen Bond Ai Drug Design Virtual Screening Target Prediction Protein Dynamics Cancer Research Infectious Diseases

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.